Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) Short Interest Down 46.7% in July

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) saw a significant decline in short interest in July. As of July 31st, there was short interest totaling 2,344 shares, a decline of 46.7% from the July 15th total of 4,398 shares. Currently, 0.1% of the company’s stock are short sold. Based on an average daily volume of 27,653 shares, the short-interest ratio is presently 0.1 days.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Aimei Health Technology in a research report on Wednesday, June 24th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, Aimei Health Technology currently has a consensus rating of “Sell”.

Aimei Health Technology Trading Down 1.6%

Aimei Health Technology stock opened at $12.00 on Tuesday. The company has a market cap of $38.04 million, a P/E ratio of 200.03 and a beta of 0.91. Aimei Health Technology has a 1-year low of $6.75 and a 1-year high of $130.37. The company has a fifty day simple moving average of $20.25 and a 200 day simple moving average of $32.35.

Aimei Health Technology (NASDAQ:AFJK) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($0.03) EPS for the quarter.

Institutional Trading of Aimei Health Technology

Institutional investors and hedge funds have recently bought and sold shares of the stock. Clear Street Group Inc. grew its stake in Aimei Health Technology by 36.5% in the fourth quarter. Clear Street Group Inc. now owns 83,337 shares of the company’s stock valued at $5,334,000 after purchasing an additional 22,294 shares in the last quarter. Jane Street Group LLC bought a new stake in shares of Aimei Health Technology during the 4th quarter worth approximately $302,000. Geode Capital Management LLC acquired a new stake in shares of Aimei Health Technology in the 4th quarter valued at approximately $413,000. Finally, Quarry LP boosted its holdings in shares of Aimei Health Technology by 6.4% in the 3rd quarter. Quarry LP now owns 167,081 shares of the company’s stock valued at $1,891,000 after buying an additional 10,000 shares during the last quarter. Institutional investors own 45.58% of the company’s stock.

Aimei Health Technology Company Profile

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.